FH Paediatric Screening
Moving Prevention From Evidence to Action:

Hybrid Event under the Auspices of the Czech EU Presidency6th September 2022

FH Europe together with Diagnoza FH, its its Czech member, are proud to announce the upcoming meeting “FH Paediatric screening moving prevention from evidence to action: overcoming the barriers to implementation” on 6 September 2022. The meeting is an accompanying event under the auspices of the Czech Presidency of the EU 2022, which started on July 1, 2022. It will be held in the Czech Senate in Prague between 13:00 and 16:30 CET.

This European event, organized by the FH patient advocacy groups, will convene thought leaders from across different sectors. It will look beyond the technical questions about FH paediatric screening that have dominated the screening debate thus far. International experts will explore specific barriers (science, funding, healthcare systems, behaviour) which are hampering the implementation of screening and how these barriers may be overcome to secure universal implementation of inherited high cholesterol screening – a solution to beating cardiovascular diseases (CVD) and building cardiovascular health (CVH) across Europe.

To ensure that this meeting accelerates action and implementation, an output of the event will be a Prague Declaration – a clear blueprint of what is now needed to overcome barriers and implement FH paediatric screening programmes throughout Europe.

Find out more about FH – an unresolved cardiovascular public health issue …

Prague Declaration

The outcome of this meeting is a political document – the Prague Declaration.